PMID- 30389367
OWN - NLM
STAT- MEDLINE
DCOM- 20190116
LR  - 20190116
IS  - 1444-2892 (Electronic)
IS  - 1443-9506 (Linking)
VI  - 28
IP  - 1
DP  - 2019 Jan
TI  - Current Device Therapies for Sudden Cardiac Death Prevention - the ICD, 
      Subcutaneous ICD and Wearable ICD.
PG  - 65-75
LID - S1443-9506(18)31920-6 [pii]
LID - 10.1016/j.hlc.2018.09.011 [doi]
AB  - Defibrillator technology for sudden cardiac death (SCD) prevention now includes 
      the transvenous implantable cardiac defibrillator (ICD), subcutaneous ICD (S-ICD) 
      and wearable cardioverter defibrillator (WCD). ICD use improves survival in 
      patients who survived previous sudden cardiac arrest (SCA) due to ventricular 
      tachycardia (VT)/ventricular fibrillation (VF), as well as in patients who 
      experienced haemodynamically significant VT. It is also currently indicated for 
      primary prevention in ischaemic/non-ischaemic cardiomyopathies, certain 
      congenital heart disease conditions and inherited channelopathies. In this review 
      article, we hope to present an updated review on ICD use for SCD prevention, with 
      a focus on contemporary issues affecting ICD selection. These include: the role 
      of primary prevention ICD in patients with non-ischaemic cardiomyopathy (NICM) in 
      light of the 2016 DANISH (Danish Study to Assess the Efficacy of ICDs in Patients 
      with Non-Ischemic Systolic Heart Failure on Mortality) trial; the role of 
      defibrillator component (CRT-D) in patients receiving cardiac resynchronisation 
      therapy (CRT-P); and the emerging role of cardiac magnetic resonance imaging 
      (cMRI) in particular, the presence of late gadolinium enhancement (LGE), as an 
      important SCD risk predictor. The current use of S-ICD and WCD, including 
      clinical indications, evidence for efficacy and limitations, will also be 
      discussed.
CI  - Copyright (c) 2018 Australian and New Zealand Society of Cardiac and Thoracic 
      Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). 
      Published by Elsevier B.V. All rights reserved.
FAU - Chieng, David
AU  - Chieng D
AD  - Department of Cardiology, Fiona Stanley Hospital, Perth, WA, Australia; 
      Department of Cardiology, Royal Perth Hospital, Perth, WA, Australia. Electronic 
      address: david.chieng@health.wa.gov.au.
FAU - Paul, Vince
AU  - Paul V
AD  - Department of Cardiology, Fiona Stanley Hospital, Perth, WA, Australia.
FAU - Denman, Russell
AU  - Denman R
AD  - Department of Cardiology, Prince Charles Hospital, Brisbane, Qld, Australia.
LA  - eng
PT  - Journal Article
PT  - Systematic Review
DEP - 20181011
PL  - Australia
TA  - Heart Lung Circ
JT  - Heart, lung & circulation
JID - 100963739
SB  - IM
MH  - Death, Sudden, Cardiac/*prevention & control
MH  - *Defibrillators, Implantable
MH  - Electric Countershock/*instrumentation
MH  - Equipment Design
MH  - Humans
MH  - *Wearable Electronic Devices
OTO - NOTNLM
OT  - Cardiac MRI
OT  - Cardiac Resynchronisation Therapy
OT  - Implantable cardiac defibrillator
OT  - Subcutaneous-ICD
OT  - Sudden cardiac death
OT  - Wearable ICD
EDAT- 2018/11/06 06:00
MHDA- 2019/01/17 06:00
CRDT- 2018/11/04 06:00
PHST- 2018/08/22 00:00 [received]
PHST- 2018/09/23 00:00 [accepted]
PHST- 2018/11/06 06:00 [pubmed]
PHST- 2019/01/17 06:00 [medline]
PHST- 2018/11/04 06:00 [entrez]
AID - S1443-9506(18)31920-6 [pii]
AID - 10.1016/j.hlc.2018.09.011 [doi]
PST - ppublish
SO  - Heart Lung Circ. 2019 Jan;28(1):65-75. doi: 10.1016/j.hlc.2018.09.011. Epub 2018 
      Oct 11.